Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors-Reference-Cited by-同舟云学术

Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

Published:2011-08-08 Issue:8 Volume:130 Page:1937-1947
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Pesonen Sari,Diaconu Iulia,Cerullo Vincenzo,Escutenaire Sophie,Raki Mari,Kangasniemi Lotta,Nokisalmi Petri,Dotti Gianpietro,Guse Kilian,Laasonen Leena,Partanen Kaarina,Karli Eerika,Haavisto Elina,Oksanen Minna,Karioja-Kallio Aila,Hannuksela Päivi,Holm Sirkka-Liisa,Kauppinen Satu,Joensuu Timo,Kanerva Anna,Hemminki Akseli

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Live viruses in cancer treatment;Nemunaitis;Oncology (Williston Park),2002

2. A smart move against cancer for vaccinia virus;Alemany;Lancet Oncol,2008

3. Immunotherapeutic potential of oncolytic virotherapy;Prestwich;Lancet Oncol,2008

4. In situ adenovirus vaccination engages T effector cells against cancer;Tuve;Vaccine,2009

5. Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy;VanOosten;Cancer Res,2007

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation of oncolytic viruses in sarcoma;Molecular Therapy: Oncology;2024-09

2. Emerging delivery strategy for oncolytic virotherapy;Molecular Therapy: Oncology;2024-06

3. Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem Cells;Viruses;2024-04-05

4. Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations;Pharmacology & Therapeutics;2024-04

5. Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation;Heliyon;2024-02